MYOS RENS, BioNutrition/ BioTherapeutics company focused on development and commercialization of products that improve muscle health and reduce frailty. $MYOS

Joined February 2014
Photos and videos
MYOS RENS Launches RACE-Approved Continuing Education Course for Veterinarians on June 10, 2020 prn.to/2XW3BTM

2
1
MYOS Announces Distribution Agreement with BodyLogicMD, a Leading Nationwide Network of Anti-Aging Medical Practices prn.to/2yH6oYu

1
1
MYOS RENS Technology Announces the Date for First Quarter 2020 Conference Call and Webcast prn.to/2Wu2rxY

2
MYOS RENS Announces that Multiple Top-Tier Pet Insurance Companies Now Cover its Canine Nutrition Products prn.to/2xWmBIZ

MYOS RENS Technology Announces Date of Fourth Quarter 2019 Financial Results, Conference Call and Webcast prn.to/2xb3UQK

1
MYOS RENS Technology to Provide Exciting Updates on New Product and Clinical Research at the Veterinary Meeting & ... prn.to/2QT7Z3F

MYOS CEO Joseph Mannello Issues Letter to Shareholders prn.to/303PaxA

Albert Ahn, DVM, Expert in Animal Medicine, Joins MYOS as Strategic Adviser to Build Veterinary Business Focused on Muscle Health accesswire.com/570452/Albert…

1
MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders Summarizing Milestone Achievements and Ongo... prn.to/378BaFR

1
MYOS RENS Technology Reports Third Quarter 2019 Financial Results Including Year-Over-Year Revenue Growth of 430% prn.to/33s6uxi

MYOS RENS Technology Launches Exclusive 'Veterinarian Strength' Myos Canine Muscle Formula prn.to/36BO1QM

MYOS RENS Technology Enters into Research Agreement with McMaster University to Study Impact of Fortetropin® on Mu... prn.to/2LGNJP1